-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
L-Norleucine-[d9]
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1331889-36-1.gif)
| Category | Influenza Virus |
| CAS | 1331889-36-1 |
| Description | L-Norleucine-[d9] is the labelled analogue of Norleucine, a non-essential amino acid. Used as an internal standard in amino acid analysis. |
Product Information
| Synonyms | L-2-Aminohexanoic-3,3,4,4,5,5,6,6,6-d9 Acid; L-Norleucine D9; (S)-2-Aminohexanoic Acid-d9; (S)-Norleucine-d9; (S)-α-Aminohexanoic Acid-d9; Glycoleucine-d9; (S)-2-Aminohexanoic Acid-d9; L-(+)-Norleucine-d9; L-2-Aminohexanoic Acid-d9; NSC 10378-d9; NSC 74430-d9; Norleucine-d9 |
| IUPAC Name | (2S)-2-amino-3,3,4,4,5,5,6,6,6-nonadeuteriohexanoic acid |
| Molecular Weight | 140.23 |
| Molecular Formula | C6H4D9NO2 |
| Canonical SMILES | CCCCC(C(=O)O)N |
| InChI | InChI=1S/C6H13NO2/c1-2-3-4-5(7)6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m0/s1/i1D3,2D2,3D2,4D2 |
| InChIKey | LRQKBLKVPFOOQJ-PLJAHZBCSA-N |
| Boiling Point | 234.0±23.0 °C at 760 mmHg |
| Melting Point | >203°C (dec.) |
| Flash Point | 95.3±22.6 °C |
| Purity | 98% by CP; 98% atom D |
| Density | 1.0±0.1 g/cm3 |
| Solubility | Slightly soluble in Aqueous Acid, Methanol |
| Appearance | White to Off-white Solid |
| Storage | Store at RT |
| Complexity | 93.1 |
| Exact Mass | 140.151119371 |
| Index Of Refraction | 1.465 |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and Metabolic profiles of drugs. |
| Target | Influenza Virus; Endogenous Metabolite |
| Vapor Pressure | 0.0±1.0 mmHg at 25°C |
| XLogP3-AA | -1.5 |
